QA: Immucell CORP DE in us_medicinal_products/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000811641_2025_Immucell_CORP_DE.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}

Graph

Absolute values for 0000811641, Immucell CORP DE

  xvar xval
0 LiabilitiesNoncurrent 13,170,077
1 LiabilitiesCurrent 4,412,213
2 remainder_Liabilities 0
3 AssetsCurrent 15,042,750
4 AssetsNoncurrent 4,594,047
5 PropertyPlantAndEquipmentNet 25,349,019
6 Goodwill 114,661
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 24,234,746
9 ResearchAndDevelopmentExpense 3,898,582
10 remainder_Expenses 10,056
11 remainder_Revenues 26,493,169
12 remainder_NetIncome -506,414
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 17,582,290
1 Assets 45,100,477
2 Expenses 28,143,384
3 Revenues 26,493,169
4 StockholdersEquity 27,518,187
5 NetIncome -2,156,629
6 ComprehensiveNetIncome -2,156,629
7 BaseVar 58,912,867
8 EconomicCapitalRatiobeforeLimitedLiability 1.13
9 EconomicCapitalRatio 1.77

Edgar->Model Mapping

Feature Distribution

Change over Time